MARCH5 heterozygous (MARCH5+/−) mice subjected to transverse aortic constriction (TAC) demonstrated alleviation of cardiac hypertrophy and improvement in cardiac function, whereas MARCH5 overexpression aggravated hypertrophy and cardiac dysfunction. This evidence concerns the gene MARCHF5 and cardiac hypertrophy.